Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Nosopharm
481
Nosopharm
Technology
Biotechnology
Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery, targeting the bacterial multidrug resistance to antibiotics.
Suggest edits
Type
B2c
Raised
$3.8M
Follow us
Companies in the same industry
PhoreMost Ltd
GeneSort
Apse
Propagenix
Aerpio Therapeutics, Inc.
Onxeo S.A.
Oventus
PHARMAJET
ATRO Medical BV
Intralytix
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
12 Feb
2018
€1,000,000
Debt financing
Bpifrance
Nosopharm Receives €1M Loan from Bpifrance
FinSMEs
28 Mar
2017
€2,400,000
Venture capital
Auriga Partners
,
Alto Invest
,
KREAXI
Nosopharm Raises €2.4M in Funding
FinSMEs
